nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—CYP2D6—breast cancer	0.105	0.389	CbGaD
Reboxetine—CYP3A4—breast cancer	0.0897	0.334	CbGaD
Reboxetine—Orphenadrine—Toremifene—breast cancer	0.0847	0.325	CrCrCtD
Reboxetine—Diphenhydramine—Toremifene—breast cancer	0.0752	0.289	CrCrCtD
Reboxetine—ABCB1—breast cancer	0.0747	0.278	CbGaD
Reboxetine—Orphenadrine—Tamoxifen—breast cancer	0.0532	0.204	CrCrCtD
Reboxetine—Diphenhydramine—Tamoxifen—breast cancer	0.0472	0.181	CrCrCtD
Reboxetine—ABCB1—Toremifene—breast cancer	0.0231	0.0776	CbGbCtD
Reboxetine—CYP3A4—Exemestane—breast cancer	0.02	0.0671	CbGbCtD
Reboxetine—CYP2D6—Idarubicin—breast cancer	0.0181	0.0606	CbGbCtD
Reboxetine—CYP3A4—Letrozole—breast cancer	0.017	0.057	CbGbCtD
Reboxetine—ABCB1—Lapatinib—breast cancer	0.0169	0.0566	CbGbCtD
Reboxetine—CYP3A4—Anastrozole—breast cancer	0.0152	0.0508	CbGbCtD
Reboxetine—CYP3A4—Toremifene—breast cancer	0.0139	0.0465	CbGbCtD
Reboxetine—CYP3A4—Fulvestrant—breast cancer	0.0129	0.0432	CbGbCtD
Reboxetine—CYP3A4—Thiotepa—breast cancer	0.0115	0.0385	CbGbCtD
Reboxetine—CYP3A4—Ixabepilone—breast cancer	0.0105	0.0352	CbGbCtD
Reboxetine—CYP3A4—Lapatinib—breast cancer	0.0101	0.0339	CbGbCtD
Reboxetine—ABCB1—Vinorelbine—breast cancer	0.00936	0.0314	CbGbCtD
Reboxetine—CYP2D6—Vinorelbine—breast cancer	0.00882	0.0296	CbGbCtD
Reboxetine—ABCB1—Tamoxifen—breast cancer	0.00845	0.0284	CbGbCtD
Reboxetine—ABCB1—Mitoxantrone—breast cancer	0.00824	0.0277	CbGbCtD
Reboxetine—CYP2D6—Tamoxifen—breast cancer	0.00796	0.0267	CbGbCtD
Reboxetine—CYP3A4—Raloxifene—breast cancer	0.00767	0.0257	CbGbCtD
Reboxetine—ABCB1—Gemcitabine—breast cancer	0.00728	0.0244	CbGbCtD
Reboxetine—ABCB1—Paclitaxel—breast cancer	0.00658	0.0221	CbGbCtD
Reboxetine—ABCB1—Irinotecan—breast cancer	0.00649	0.0218	CbGbCtD
Reboxetine—ABCB1—Vinblastine—breast cancer	0.00577	0.0194	CbGbCtD
Reboxetine—CYP3A4—Vinorelbine—breast cancer	0.00561	0.0188	CbGbCtD
Reboxetine—CYP2D6—Vinblastine—breast cancer	0.00544	0.0182	CbGbCtD
Reboxetine—CYP3A4—Tamoxifen—breast cancer	0.00506	0.017	CbGbCtD
Reboxetine—CYP3A4—Mitoxantrone—breast cancer	0.00494	0.0166	CbGbCtD
Reboxetine—ABCB1—Docetaxel—breast cancer	0.00476	0.016	CbGbCtD
Reboxetine—CYP3A4—Paclitaxel—breast cancer	0.00394	0.0132	CbGbCtD
Reboxetine—CYP3A4—Irinotecan—breast cancer	0.00389	0.013	CbGbCtD
Reboxetine—ABCB1—Doxorubicin—breast cancer	0.00355	0.0119	CbGbCtD
Reboxetine—CYP3A4—Vinblastine—breast cancer	0.00346	0.0116	CbGbCtD
Reboxetine—ABCB1—Methotrexate—breast cancer	0.00344	0.0115	CbGbCtD
Reboxetine—CYP2D6—Doxorubicin—breast cancer	0.00334	0.0112	CbGbCtD
Reboxetine—CYP3A4—Docetaxel—breast cancer	0.00285	0.00956	CbGbCtD
Reboxetine—CYP3A4—Doxorubicin—breast cancer	0.00212	0.00713	CbGbCtD
Reboxetine—Orphenadrine—SCN10A—breast cancer	0.000185	0.223	CrCbGaD
Reboxetine—Benzatropine—CYP2D6—breast cancer	0.000117	0.141	CrCbGaD
Reboxetine—Phenprocoumon—CYP3A4—breast cancer	0.000102	0.123	CrCbGaD
Reboxetine—Phenprocoumon—ALB—breast cancer	8.92e-05	0.108	CrCbGaD
Reboxetine—Diphenhydramine—PTGS1—breast cancer	8.84e-05	0.107	CrCbGaD
Reboxetine—Atomoxetine—CYP2D6—breast cancer	7.45e-05	0.0898	CrCbGaD
Reboxetine—Atomoxetine—CYP3A4—breast cancer	6.39e-05	0.077	CrCbGaD
Reboxetine—Diphenhydramine—CYP2D6—breast cancer	6.02e-05	0.0725	CrCbGaD
Reboxetine—Orphenadrine—CYP3A4—breast cancer	4.88e-05	0.0588	CrCbGaD
Reboxetine—Urticaria—Paclitaxel—breast cancer	3.32e-05	0.000245	CcSEcCtD
Reboxetine—Hyperhidrosis—Capecitabine—breast cancer	3.31e-05	0.000244	CcSEcCtD
Reboxetine—Hypotension—Docetaxel—breast cancer	3.31e-05	0.000244	CcSEcCtD
Reboxetine—Connective tissue disorder—Epirubicin—breast cancer	3.3e-05	0.000243	CcSEcCtD
Reboxetine—Abdominal pain—Paclitaxel—breast cancer	3.3e-05	0.000243	CcSEcCtD
Reboxetine—Body temperature increased—Paclitaxel—breast cancer	3.3e-05	0.000243	CcSEcCtD
Reboxetine—Urethral disorder—Epirubicin—breast cancer	3.29e-05	0.000243	CcSEcCtD
Reboxetine—Epistaxis—Doxorubicin—breast cancer	3.27e-05	0.000241	CcSEcCtD
Reboxetine—Anorexia—Capecitabine—breast cancer	3.27e-05	0.000241	CcSEcCtD
Reboxetine—Angiopathy—Methotrexate—breast cancer	3.26e-05	0.00024	CcSEcCtD
Reboxetine—Vomiting—Irinotecan—breast cancer	3.26e-05	0.00024	CcSEcCtD
Reboxetine—Vomiting—Mitoxantrone—breast cancer	3.26e-05	0.00024	CcSEcCtD
Reboxetine—Sinusitis—Doxorubicin—breast cancer	3.25e-05	0.00024	CcSEcCtD
Reboxetine—Immune system disorder—Methotrexate—breast cancer	3.24e-05	0.000239	CcSEcCtD
Reboxetine—Dizziness—Fluorouracil—breast cancer	3.24e-05	0.000239	CcSEcCtD
Reboxetine—Visual impairment—Epirubicin—breast cancer	3.24e-05	0.000239	CcSEcCtD
Reboxetine—Mediastinal disorder—Methotrexate—breast cancer	3.24e-05	0.000239	CcSEcCtD
Reboxetine—Rash—Irinotecan—breast cancer	3.23e-05	0.000238	CcSEcCtD
Reboxetine—Rash—Mitoxantrone—breast cancer	3.23e-05	0.000238	CcSEcCtD
Reboxetine—Dermatitis—Irinotecan—breast cancer	3.23e-05	0.000238	CcSEcCtD
Reboxetine—Dermatitis—Mitoxantrone—breast cancer	3.23e-05	0.000238	CcSEcCtD
Reboxetine—Chills—Methotrexate—breast cancer	3.22e-05	0.000238	CcSEcCtD
Reboxetine—Headache—Irinotecan—breast cancer	3.21e-05	0.000237	CcSEcCtD
Reboxetine—Headache—Mitoxantrone—breast cancer	3.21e-05	0.000237	CcSEcCtD
Reboxetine—Hypotension—Capecitabine—breast cancer	3.2e-05	0.000236	CcSEcCtD
Reboxetine—Insomnia—Docetaxel—breast cancer	3.2e-05	0.000236	CcSEcCtD
Reboxetine—Paraesthesia—Docetaxel—breast cancer	3.18e-05	0.000234	CcSEcCtD
Reboxetine—Vomiting—Gemcitabine—breast cancer	3.17e-05	0.000234	CcSEcCtD
Reboxetine—Bradycardia—Doxorubicin—breast cancer	3.17e-05	0.000233	CcSEcCtD
Reboxetine—Dyspnoea—Docetaxel—breast cancer	3.16e-05	0.000233	CcSEcCtD
Reboxetine—Somnolence—Docetaxel—breast cancer	3.15e-05	0.000232	CcSEcCtD
Reboxetine—Mental disorder—Methotrexate—breast cancer	3.15e-05	0.000232	CcSEcCtD
Reboxetine—Rash—Gemcitabine—breast cancer	3.15e-05	0.000232	CcSEcCtD
Reboxetine—Dermatitis—Gemcitabine—breast cancer	3.14e-05	0.000232	CcSEcCtD
Reboxetine—Eye disorder—Epirubicin—breast cancer	3.14e-05	0.000232	CcSEcCtD
Reboxetine—Tinnitus—Epirubicin—breast cancer	3.13e-05	0.000231	CcSEcCtD
Reboxetine—Malnutrition—Methotrexate—breast cancer	3.13e-05	0.00023	CcSEcCtD
Reboxetine—Headache—Gemcitabine—breast cancer	3.13e-05	0.00023	CcSEcCtD
Reboxetine—Cardiac disorder—Epirubicin—breast cancer	3.12e-05	0.00023	CcSEcCtD
Reboxetine—Vomiting—Fluorouracil—breast cancer	3.12e-05	0.00023	CcSEcCtD
Reboxetine—Rhinitis—Doxorubicin—breast cancer	3.12e-05	0.00023	CcSEcCtD
Reboxetine—Dyspepsia—Docetaxel—breast cancer	3.12e-05	0.00023	CcSEcCtD
Reboxetine—Insomnia—Capecitabine—breast cancer	3.1e-05	0.000229	CcSEcCtD
Reboxetine—Rash—Fluorouracil—breast cancer	3.09e-05	0.000228	CcSEcCtD
Reboxetine—Dermatitis—Fluorouracil—breast cancer	3.09e-05	0.000228	CcSEcCtD
Reboxetine—Pharyngitis—Doxorubicin—breast cancer	3.09e-05	0.000228	CcSEcCtD
Reboxetine—Paraesthesia—Capecitabine—breast cancer	3.08e-05	0.000227	CcSEcCtD
Reboxetine—Decreased appetite—Docetaxel—breast cancer	3.08e-05	0.000227	CcSEcCtD
Reboxetine—Hypersensitivity—Paclitaxel—breast cancer	3.08e-05	0.000227	CcSEcCtD
Reboxetine—Headache—Fluorouracil—breast cancer	3.07e-05	0.000227	CcSEcCtD
Reboxetine—Urinary tract disorder—Doxorubicin—breast cancer	3.07e-05	0.000226	CcSEcCtD
Reboxetine—Dysgeusia—Methotrexate—breast cancer	3.06e-05	0.000226	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Docetaxel—breast cancer	3.06e-05	0.000225	CcSEcCtD
Reboxetine—Connective tissue disorder—Doxorubicin—breast cancer	3.06e-05	0.000225	CcSEcCtD
Reboxetine—Dyspnoea—Capecitabine—breast cancer	3.06e-05	0.000225	CcSEcCtD
Reboxetine—Angiopathy—Epirubicin—breast cancer	3.05e-05	0.000225	CcSEcCtD
Reboxetine—Urethral disorder—Doxorubicin—breast cancer	3.05e-05	0.000225	CcSEcCtD
Reboxetine—Nausea—Mitoxantrone—breast cancer	3.04e-05	0.000224	CcSEcCtD
Reboxetine—Nausea—Irinotecan—breast cancer	3.04e-05	0.000224	CcSEcCtD
Reboxetine—Immune system disorder—Epirubicin—breast cancer	3.04e-05	0.000224	CcSEcCtD
Reboxetine—Mediastinal disorder—Epirubicin—breast cancer	3.03e-05	0.000223	CcSEcCtD
Reboxetine—Constipation—Docetaxel—breast cancer	3.03e-05	0.000223	CcSEcCtD
Reboxetine—Dyspepsia—Capecitabine—breast cancer	3.02e-05	0.000222	CcSEcCtD
Reboxetine—Chills—Epirubicin—breast cancer	3.02e-05	0.000222	CcSEcCtD
Reboxetine—Visual impairment—Doxorubicin—breast cancer	3e-05	0.000221	CcSEcCtD
Reboxetine—Asthenia—Paclitaxel—breast cancer	3e-05	0.000221	CcSEcCtD
Reboxetine—Decreased appetite—Capecitabine—breast cancer	2.98e-05	0.00022	CcSEcCtD
Reboxetine—Nausea—Gemcitabine—breast cancer	2.96e-05	0.000218	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Capecitabine—breast cancer	2.96e-05	0.000218	CcSEcCtD
Reboxetine—Mental disorder—Epirubicin—breast cancer	2.94e-05	0.000217	CcSEcCtD
Reboxetine—Constipation—Capecitabine—breast cancer	2.93e-05	0.000216	CcSEcCtD
Reboxetine—Malnutrition—Epirubicin—breast cancer	2.93e-05	0.000216	CcSEcCtD
Reboxetine—Feeling abnormal—Docetaxel—breast cancer	2.92e-05	0.000215	CcSEcCtD
Reboxetine—Nausea—Fluorouracil—breast cancer	2.91e-05	0.000215	CcSEcCtD
Reboxetine—Eye disorder—Doxorubicin—breast cancer	2.91e-05	0.000214	CcSEcCtD
Reboxetine—Ill-defined disorder—Methotrexate—breast cancer	2.9e-05	0.000214	CcSEcCtD
Reboxetine—Tinnitus—Doxorubicin—breast cancer	2.9e-05	0.000214	CcSEcCtD
Reboxetine—Gastrointestinal pain—Docetaxel—breast cancer	2.9e-05	0.000213	CcSEcCtD
Reboxetine—Anaemia—Methotrexate—breast cancer	2.89e-05	0.000213	CcSEcCtD
Reboxetine—Cardiac disorder—Doxorubicin—breast cancer	2.89e-05	0.000213	CcSEcCtD
Reboxetine—Tension—Epirubicin—breast cancer	2.87e-05	0.000212	CcSEcCtD
Reboxetine—Dysgeusia—Epirubicin—breast cancer	2.87e-05	0.000211	CcSEcCtD
Reboxetine—Diarrhoea—Paclitaxel—breast cancer	2.86e-05	0.000211	CcSEcCtD
Reboxetine—Nervousness—Epirubicin—breast cancer	2.84e-05	0.00021	CcSEcCtD
Reboxetine—Feeling abnormal—Capecitabine—breast cancer	2.82e-05	0.000208	CcSEcCtD
Reboxetine—Angiopathy—Doxorubicin—breast cancer	2.82e-05	0.000208	CcSEcCtD
Reboxetine—Malaise—Methotrexate—breast cancer	2.82e-05	0.000208	CcSEcCtD
Reboxetine—Immune system disorder—Doxorubicin—breast cancer	2.81e-05	0.000207	CcSEcCtD
Reboxetine—Vertigo—Methotrexate—breast cancer	2.81e-05	0.000207	CcSEcCtD
Reboxetine—Gastrointestinal pain—Capecitabine—breast cancer	2.8e-05	0.000207	CcSEcCtD
Reboxetine—Mediastinal disorder—Doxorubicin—breast cancer	2.8e-05	0.000207	CcSEcCtD
Reboxetine—Abdominal pain—Docetaxel—breast cancer	2.8e-05	0.000206	CcSEcCtD
Reboxetine—Body temperature increased—Docetaxel—breast cancer	2.8e-05	0.000206	CcSEcCtD
Reboxetine—Leukopenia—Methotrexate—breast cancer	2.8e-05	0.000206	CcSEcCtD
Reboxetine—Chills—Doxorubicin—breast cancer	2.79e-05	0.000206	CcSEcCtD
Reboxetine—Dizziness—Paclitaxel—breast cancer	2.76e-05	0.000204	CcSEcCtD
Reboxetine—Mental disorder—Doxorubicin—breast cancer	2.72e-05	0.000201	CcSEcCtD
Reboxetine—Urticaria—Capecitabine—breast cancer	2.72e-05	0.000201	CcSEcCtD
Reboxetine—Ill-defined disorder—Epirubicin—breast cancer	2.71e-05	0.0002	CcSEcCtD
Reboxetine—Abdominal pain—Capecitabine—breast cancer	2.71e-05	0.0002	CcSEcCtD
Reboxetine—Body temperature increased—Capecitabine—breast cancer	2.71e-05	0.0002	CcSEcCtD
Reboxetine—Malnutrition—Doxorubicin—breast cancer	2.71e-05	0.0002	CcSEcCtD
Reboxetine—Anaemia—Epirubicin—breast cancer	2.7e-05	0.000199	CcSEcCtD
Reboxetine—Agitation—Epirubicin—breast cancer	2.69e-05	0.000198	CcSEcCtD
Reboxetine—Chest pain—Methotrexate—breast cancer	2.66e-05	0.000196	CcSEcCtD
Reboxetine—Tension—Doxorubicin—breast cancer	2.66e-05	0.000196	CcSEcCtD
Reboxetine—Vomiting—Paclitaxel—breast cancer	2.66e-05	0.000196	CcSEcCtD
Reboxetine—Dysgeusia—Doxorubicin—breast cancer	2.65e-05	0.000195	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.64e-05	0.000195	CcSEcCtD
Reboxetine—Malaise—Epirubicin—breast cancer	2.64e-05	0.000195	CcSEcCtD
Reboxetine—Rash—Paclitaxel—breast cancer	2.63e-05	0.000194	CcSEcCtD
Reboxetine—Dermatitis—Paclitaxel—breast cancer	2.63e-05	0.000194	CcSEcCtD
Reboxetine—Discomfort—Methotrexate—breast cancer	2.63e-05	0.000194	CcSEcCtD
Reboxetine—Nervousness—Doxorubicin—breast cancer	2.63e-05	0.000194	CcSEcCtD
Reboxetine—Vertigo—Epirubicin—breast cancer	2.63e-05	0.000194	CcSEcCtD
Reboxetine—Syncope—Epirubicin—breast cancer	2.62e-05	0.000193	CcSEcCtD
Reboxetine—Leukopenia—Epirubicin—breast cancer	2.62e-05	0.000193	CcSEcCtD
Reboxetine—Headache—Paclitaxel—breast cancer	2.62e-05	0.000193	CcSEcCtD
Reboxetine—Hypersensitivity—Docetaxel—breast cancer	2.61e-05	0.000192	CcSEcCtD
Reboxetine—Palpitations—Epirubicin—breast cancer	2.59e-05	0.000191	CcSEcCtD
Reboxetine—Confusional state—Methotrexate—breast cancer	2.57e-05	0.00019	CcSEcCtD
Reboxetine—Loss of consciousness—Epirubicin—breast cancer	2.57e-05	0.00019	CcSEcCtD
Reboxetine—Asthenia—Docetaxel—breast cancer	2.54e-05	0.000187	CcSEcCtD
Reboxetine—Infection—Methotrexate—breast cancer	2.54e-05	0.000187	CcSEcCtD
Reboxetine—Hypertension—Epirubicin—breast cancer	2.53e-05	0.000186	CcSEcCtD
Reboxetine—Hypersensitivity—Capecitabine—breast cancer	2.53e-05	0.000186	CcSEcCtD
Reboxetine—Ill-defined disorder—Doxorubicin—breast cancer	2.51e-05	0.000185	CcSEcCtD
Reboxetine—Nervous system disorder—Methotrexate—breast cancer	2.5e-05	0.000184	CcSEcCtD
Reboxetine—Anaemia—Doxorubicin—breast cancer	2.5e-05	0.000184	CcSEcCtD
Reboxetine—Chest pain—Epirubicin—breast cancer	2.49e-05	0.000184	CcSEcCtD
Reboxetine—Agitation—Doxorubicin—breast cancer	2.49e-05	0.000183	CcSEcCtD
Reboxetine—Anxiety—Epirubicin—breast cancer	2.48e-05	0.000183	CcSEcCtD
Reboxetine—Nausea—Paclitaxel—breast cancer	2.48e-05	0.000183	CcSEcCtD
Reboxetine—Skin disorder—Methotrexate—breast cancer	2.48e-05	0.000183	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.47e-05	0.000182	CcSEcCtD
Reboxetine—Hyperhidrosis—Methotrexate—breast cancer	2.47e-05	0.000182	CcSEcCtD
Reboxetine—Discomfort—Epirubicin—breast cancer	2.46e-05	0.000181	CcSEcCtD
Reboxetine—Asthenia—Capecitabine—breast cancer	2.46e-05	0.000181	CcSEcCtD
Reboxetine—Malaise—Doxorubicin—breast cancer	2.44e-05	0.00018	CcSEcCtD
Reboxetine—Dry mouth—Epirubicin—breast cancer	2.44e-05	0.00018	CcSEcCtD
Reboxetine—Vertigo—Doxorubicin—breast cancer	2.43e-05	0.000179	CcSEcCtD
Reboxetine—Anorexia—Methotrexate—breast cancer	2.43e-05	0.000179	CcSEcCtD
Reboxetine—Syncope—Doxorubicin—breast cancer	2.43e-05	0.000179	CcSEcCtD
Reboxetine—Leukopenia—Doxorubicin—breast cancer	2.42e-05	0.000179	CcSEcCtD
Reboxetine—Diarrhoea—Docetaxel—breast cancer	2.42e-05	0.000179	CcSEcCtD
Reboxetine—Confusional state—Epirubicin—breast cancer	2.41e-05	0.000178	CcSEcCtD
Reboxetine—Palpitations—Doxorubicin—breast cancer	2.39e-05	0.000176	CcSEcCtD
Reboxetine—Hypotension—Methotrexate—breast cancer	2.38e-05	0.000176	CcSEcCtD
Reboxetine—Loss of consciousness—Doxorubicin—breast cancer	2.38e-05	0.000175	CcSEcCtD
Reboxetine—Infection—Epirubicin—breast cancer	2.37e-05	0.000175	CcSEcCtD
Reboxetine—Shock—Epirubicin—breast cancer	2.35e-05	0.000173	CcSEcCtD
Reboxetine—Diarrhoea—Capecitabine—breast cancer	2.35e-05	0.000173	CcSEcCtD
Reboxetine—Nervous system disorder—Epirubicin—breast cancer	2.34e-05	0.000173	CcSEcCtD
Reboxetine—Dizziness—Docetaxel—breast cancer	2.34e-05	0.000173	CcSEcCtD
Reboxetine—Hypertension—Doxorubicin—breast cancer	2.34e-05	0.000172	CcSEcCtD
Reboxetine—Tachycardia—Epirubicin—breast cancer	2.33e-05	0.000172	CcSEcCtD
Reboxetine—Skin disorder—Epirubicin—breast cancer	2.32e-05	0.000171	CcSEcCtD
Reboxetine—Hyperhidrosis—Epirubicin—breast cancer	2.31e-05	0.00017	CcSEcCtD
Reboxetine—Insomnia—Methotrexate—breast cancer	2.31e-05	0.00017	CcSEcCtD
Reboxetine—Chest pain—Doxorubicin—breast cancer	2.3e-05	0.00017	CcSEcCtD
Reboxetine—Anxiety—Doxorubicin—breast cancer	2.3e-05	0.000169	CcSEcCtD
Reboxetine—Paraesthesia—Methotrexate—breast cancer	2.29e-05	0.000169	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.29e-05	0.000169	CcSEcCtD
Reboxetine—Discomfort—Doxorubicin—breast cancer	2.28e-05	0.000168	CcSEcCtD
Reboxetine—Anorexia—Epirubicin—breast cancer	2.28e-05	0.000168	CcSEcCtD
Reboxetine—Dyspnoea—Methotrexate—breast cancer	2.28e-05	0.000168	CcSEcCtD
Reboxetine—Somnolence—Methotrexate—breast cancer	2.27e-05	0.000167	CcSEcCtD
Reboxetine—Dizziness—Capecitabine—breast cancer	2.27e-05	0.000167	CcSEcCtD
Reboxetine—Dry mouth—Doxorubicin—breast cancer	2.25e-05	0.000166	CcSEcCtD
Reboxetine—Vomiting—Docetaxel—breast cancer	2.25e-05	0.000166	CcSEcCtD
Reboxetine—Dyspepsia—Methotrexate—breast cancer	2.25e-05	0.000166	CcSEcCtD
Reboxetine—Rash—Docetaxel—breast cancer	2.23e-05	0.000165	CcSEcCtD
Reboxetine—Hypotension—Epirubicin—breast cancer	2.23e-05	0.000165	CcSEcCtD
Reboxetine—Dermatitis—Docetaxel—breast cancer	2.23e-05	0.000164	CcSEcCtD
Reboxetine—Confusional state—Doxorubicin—breast cancer	2.23e-05	0.000164	CcSEcCtD
Reboxetine—Decreased appetite—Methotrexate—breast cancer	2.22e-05	0.000164	CcSEcCtD
Reboxetine—Headache—Docetaxel—breast cancer	2.22e-05	0.000164	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Methotrexate—breast cancer	2.2e-05	0.000162	CcSEcCtD
Reboxetine—Infection—Doxorubicin—breast cancer	2.2e-05	0.000162	CcSEcCtD
Reboxetine—Vomiting—Capecitabine—breast cancer	2.18e-05	0.000161	CcSEcCtD
Reboxetine—Shock—Doxorubicin—breast cancer	2.17e-05	0.00016	CcSEcCtD
Reboxetine—Nervous system disorder—Doxorubicin—breast cancer	2.17e-05	0.00016	CcSEcCtD
Reboxetine—Rash—Capecitabine—breast cancer	2.16e-05	0.000159	CcSEcCtD
Reboxetine—Insomnia—Epirubicin—breast cancer	2.16e-05	0.000159	CcSEcCtD
Reboxetine—Dermatitis—Capecitabine—breast cancer	2.16e-05	0.000159	CcSEcCtD
Reboxetine—Tachycardia—Doxorubicin—breast cancer	2.16e-05	0.000159	CcSEcCtD
Reboxetine—Headache—Capecitabine—breast cancer	2.15e-05	0.000158	CcSEcCtD
Reboxetine—Skin disorder—Doxorubicin—breast cancer	2.15e-05	0.000158	CcSEcCtD
Reboxetine—Paraesthesia—Epirubicin—breast cancer	2.14e-05	0.000158	CcSEcCtD
Reboxetine—Hyperhidrosis—Doxorubicin—breast cancer	2.14e-05	0.000157	CcSEcCtD
Reboxetine—Dyspnoea—Epirubicin—breast cancer	2.13e-05	0.000157	CcSEcCtD
Reboxetine—Somnolence—Epirubicin—breast cancer	2.12e-05	0.000157	CcSEcCtD
Reboxetine—Anorexia—Doxorubicin—breast cancer	2.11e-05	0.000155	CcSEcCtD
Reboxetine—Nausea—Docetaxel—breast cancer	2.1e-05	0.000155	CcSEcCtD
Reboxetine—Feeling abnormal—Methotrexate—breast cancer	2.1e-05	0.000155	CcSEcCtD
Reboxetine—Dyspepsia—Epirubicin—breast cancer	2.1e-05	0.000155	CcSEcCtD
Reboxetine—Gastrointestinal pain—Methotrexate—breast cancer	2.09e-05	0.000154	CcSEcCtD
Reboxetine—Decreased appetite—Epirubicin—breast cancer	2.08e-05	0.000153	CcSEcCtD
Reboxetine—Hypotension—Doxorubicin—breast cancer	2.06e-05	0.000152	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Epirubicin—breast cancer	2.06e-05	0.000152	CcSEcCtD
Reboxetine—Constipation—Epirubicin—breast cancer	2.04e-05	0.000151	CcSEcCtD
Reboxetine—Nausea—Capecitabine—breast cancer	2.04e-05	0.00015	CcSEcCtD
Reboxetine—Urticaria—Methotrexate—breast cancer	2.03e-05	0.000149	CcSEcCtD
Reboxetine—Body temperature increased—Methotrexate—breast cancer	2.02e-05	0.000149	CcSEcCtD
Reboxetine—Abdominal pain—Methotrexate—breast cancer	2.02e-05	0.000149	CcSEcCtD
Reboxetine—Insomnia—Doxorubicin—breast cancer	2e-05	0.000147	CcSEcCtD
Reboxetine—Paraesthesia—Doxorubicin—breast cancer	1.98e-05	0.000146	CcSEcCtD
Reboxetine—Dyspnoea—Doxorubicin—breast cancer	1.97e-05	0.000145	CcSEcCtD
Reboxetine—Feeling abnormal—Epirubicin—breast cancer	1.97e-05	0.000145	CcSEcCtD
Reboxetine—Somnolence—Doxorubicin—breast cancer	1.96e-05	0.000145	CcSEcCtD
Reboxetine—Gastrointestinal pain—Epirubicin—breast cancer	1.95e-05	0.000144	CcSEcCtD
Reboxetine—Dyspepsia—Doxorubicin—breast cancer	1.95e-05	0.000143	CcSEcCtD
Reboxetine—Decreased appetite—Doxorubicin—breast cancer	1.92e-05	0.000142	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Doxorubicin—breast cancer	1.91e-05	0.000141	CcSEcCtD
Reboxetine—Urticaria—Epirubicin—breast cancer	1.9e-05	0.00014	CcSEcCtD
Reboxetine—Constipation—Doxorubicin—breast cancer	1.89e-05	0.000139	CcSEcCtD
Reboxetine—Abdominal pain—Epirubicin—breast cancer	1.89e-05	0.000139	CcSEcCtD
Reboxetine—Body temperature increased—Epirubicin—breast cancer	1.89e-05	0.000139	CcSEcCtD
Reboxetine—Hypersensitivity—Methotrexate—breast cancer	1.88e-05	0.000139	CcSEcCtD
Reboxetine—Asthenia—Methotrexate—breast cancer	1.83e-05	0.000135	CcSEcCtD
Reboxetine—Feeling abnormal—Doxorubicin—breast cancer	1.82e-05	0.000134	CcSEcCtD
Reboxetine—Gastrointestinal pain—Doxorubicin—breast cancer	1.81e-05	0.000133	CcSEcCtD
Reboxetine—Hypersensitivity—Epirubicin—breast cancer	1.76e-05	0.00013	CcSEcCtD
Reboxetine—Urticaria—Doxorubicin—breast cancer	1.76e-05	0.000129	CcSEcCtD
Reboxetine—Abdominal pain—Doxorubicin—breast cancer	1.75e-05	0.000129	CcSEcCtD
Reboxetine—Body temperature increased—Doxorubicin—breast cancer	1.75e-05	0.000129	CcSEcCtD
Reboxetine—Diarrhoea—Methotrexate—breast cancer	1.75e-05	0.000129	CcSEcCtD
Reboxetine—Asthenia—Epirubicin—breast cancer	1.71e-05	0.000126	CcSEcCtD
Reboxetine—Dizziness—Methotrexate—breast cancer	1.69e-05	0.000124	CcSEcCtD
Reboxetine—Diarrhoea—Epirubicin—breast cancer	1.63e-05	0.00012	CcSEcCtD
Reboxetine—Hypersensitivity—Doxorubicin—breast cancer	1.63e-05	0.00012	CcSEcCtD
Reboxetine—Vomiting—Methotrexate—breast cancer	1.62e-05	0.00012	CcSEcCtD
Reboxetine—Rash—Methotrexate—breast cancer	1.61e-05	0.000119	CcSEcCtD
Reboxetine—Dermatitis—Methotrexate—breast cancer	1.61e-05	0.000119	CcSEcCtD
Reboxetine—Headache—Methotrexate—breast cancer	1.6e-05	0.000118	CcSEcCtD
Reboxetine—Asthenia—Doxorubicin—breast cancer	1.59e-05	0.000117	CcSEcCtD
Reboxetine—Dizziness—Epirubicin—breast cancer	1.58e-05	0.000116	CcSEcCtD
Reboxetine—Vomiting—Epirubicin—breast cancer	1.52e-05	0.000112	CcSEcCtD
Reboxetine—Nausea—Methotrexate—breast cancer	1.52e-05	0.000112	CcSEcCtD
Reboxetine—Diarrhoea—Doxorubicin—breast cancer	1.51e-05	0.000111	CcSEcCtD
Reboxetine—Rash—Epirubicin—breast cancer	1.51e-05	0.000111	CcSEcCtD
Reboxetine—Dermatitis—Epirubicin—breast cancer	1.5e-05	0.000111	CcSEcCtD
Reboxetine—Headache—Epirubicin—breast cancer	1.5e-05	0.00011	CcSEcCtD
Reboxetine—Dizziness—Doxorubicin—breast cancer	1.46e-05	0.000108	CcSEcCtD
Reboxetine—Nausea—Epirubicin—breast cancer	1.42e-05	0.000105	CcSEcCtD
Reboxetine—Vomiting—Doxorubicin—breast cancer	1.4e-05	0.000104	CcSEcCtD
Reboxetine—Rash—Doxorubicin—breast cancer	1.39e-05	0.000103	CcSEcCtD
Reboxetine—Dermatitis—Doxorubicin—breast cancer	1.39e-05	0.000103	CcSEcCtD
Reboxetine—Headache—Doxorubicin—breast cancer	1.38e-05	0.000102	CcSEcCtD
Reboxetine—Nausea—Doxorubicin—breast cancer	1.31e-05	9.68e-05	CcSEcCtD
Reboxetine—ABCB1—Metabolism—ABCG2—breast cancer	4.92e-06	0.000136	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALDOA—breast cancer	4.91e-06	0.000136	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALDH1A1—breast cancer	4.9e-06	0.000136	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALDH7A1—breast cancer	4.9e-06	0.000136	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ITPR1—breast cancer	4.88e-06	0.000135	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ERBB4—breast cancer	4.85e-06	0.000134	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—STAT5A—breast cancer	4.85e-06	0.000134	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MMP3—breast cancer	4.85e-06	0.000134	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PIK3CB—breast cancer	4.84e-06	0.000134	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HPGDS—breast cancer	4.82e-06	0.000134	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HBA1—breast cancer	4.79e-06	0.000133	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NCOA3—breast cancer	4.76e-06	0.000132	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SLC2A2—breast cancer	4.73e-06	0.000131	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ADSL—breast cancer	4.7e-06	0.00013	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PHGDH—breast cancer	4.7e-06	0.00013	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—FHL2—breast cancer	4.7e-06	0.00013	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—UMPS—breast cancer	4.7e-06	0.00013	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NME1—breast cancer	4.7e-06	0.00013	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SMAD4—breast cancer	4.7e-06	0.00013	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTT1—breast cancer	4.68e-06	0.00013	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ACHE—breast cancer	4.68e-06	0.00013	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IGF1R—breast cancer	4.67e-06	0.000129	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CXCL8—breast cancer	4.65e-06	0.000129	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CPT1A—breast cancer	4.63e-06	0.000129	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ABCG2—breast cancer	4.63e-06	0.000129	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MTR—breast cancer	4.63e-06	0.000129	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HPSE—breast cancer	4.61e-06	0.000128	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—BRIP1—breast cancer	4.61e-06	0.000128	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—LDHB—breast cancer	4.61e-06	0.000128	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HES1—breast cancer	4.59e-06	0.000127	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NCOR1—breast cancer	4.56e-06	0.000126	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PLA2G4A—breast cancer	4.56e-06	0.000126	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HPGDS—breast cancer	4.55e-06	0.000126	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	4.54e-06	0.000126	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HBA1—breast cancer	4.52e-06	0.000125	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FGF1—breast cancer	4.51e-06	0.000125	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CSF2—breast cancer	4.51e-06	0.000125	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—RAF1—breast cancer	4.5e-06	0.000125	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NRG1—breast cancer	4.48e-06	0.000124	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—H2AFX—breast cancer	4.44e-06	0.000123	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—IL2—breast cancer	4.44e-06	0.000123	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP17A1—breast cancer	4.43e-06	0.000123	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—E2F1—breast cancer	4.41e-06	0.000122	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ACHE—breast cancer	4.41e-06	0.000122	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTT1—breast cancer	4.41e-06	0.000122	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PIK3CB—breast cancer	4.39e-06	0.000122	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PTGS1—breast cancer	4.38e-06	0.000122	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ENO1—breast cancer	4.38e-06	0.000122	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCC1—breast cancer	4.37e-06	0.000121	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTA3—breast cancer	4.37e-06	0.000121	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HMMR—breast cancer	4.37e-06	0.000121	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP2D6—breast cancer	4.3e-06	0.000119	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SPP1—breast cancer	4.24e-06	0.000118	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PPARGC1B—breast cancer	4.23e-06	0.000117	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CXCL8—breast cancer	4.22e-06	0.000117	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NCOA2—breast cancer	4.22e-06	0.000117	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ERBB3—breast cancer	4.19e-06	0.000116	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FGFR2—breast cancer	4.19e-06	0.000116	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP17A1—breast cancer	4.17e-06	0.000116	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ENO1—breast cancer	4.13e-06	0.000115	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PTGS1—breast cancer	4.13e-06	0.000115	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	4.1e-06	0.000114	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—FASN—breast cancer	4.09e-06	0.000113	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—BCHE—breast cancer	4.08e-06	0.000113	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—IL2—breast cancer	4.03e-06	0.000112	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SLC5A5—breast cancer	4.03e-06	0.000112	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TERT—breast cancer	4.02e-06	0.000111	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTA4—breast cancer	4e-06	0.000111	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CA9—breast cancer	4e-06	0.000111	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NCOA2—breast cancer	3.98e-06	0.00011	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FGFR1—breast cancer	3.9e-06	0.000108	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTA2—breast cancer	3.9e-06	0.000108	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GPX2—breast cancer	3.9e-06	0.000108	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SLC2A1—breast cancer	3.89e-06	0.000108	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NQO1—breast cancer	3.89e-06	0.000108	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—FASN—breast cancer	3.86e-06	0.000107	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SULT1A1—breast cancer	3.85e-06	0.000107	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GPX4—breast cancer	3.85e-06	0.000107	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HIF1A—breast cancer	3.84e-06	0.000107	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—BCHE—breast cancer	3.84e-06	0.000106	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SLC5A5—breast cancer	3.79e-06	0.000105	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP3A4—breast cancer	3.79e-06	0.000105	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—IDH1—breast cancer	3.76e-06	0.000104	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTA1—breast cancer	3.76e-06	0.000104	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—LEP—breast cancer	3.75e-06	0.000104	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP1B1—breast cancer	3.73e-06	0.000103	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CAV1—breast cancer	3.72e-06	0.000103	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NAT2—breast cancer	3.72e-06	0.000103	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	3.71e-06	0.000103	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—KDR—breast cancer	3.68e-06	0.000102	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NQO1—breast cancer	3.66e-06	0.000102	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SLC2A1—breast cancer	3.66e-06	0.000102	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HSP90AA1—breast cancer	3.66e-06	0.000101	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ESR1—breast cancer	3.58e-06	9.93e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP3A4—breast cancer	3.57e-06	9.91e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NCOA1—breast cancer	3.56e-06	9.86e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FN1—breast cancer	3.54e-06	9.81e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP1B1—breast cancer	3.51e-06	9.74e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—STK11—breast cancer	3.5e-06	9.72e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP19A1—breast cancer	3.5e-06	9.72e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NFKBIA—breast cancer	3.5e-06	9.7e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NOTCH1—breast cancer	3.46e-06	9.6e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HSP90AA1—breast cancer	3.44e-06	9.55e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—KIT—breast cancer	3.39e-06	9.39e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PIK3CG—breast cancer	3.39e-06	9.39e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APC—breast cancer	3.39e-06	9.39e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NCOA1—breast cancer	3.35e-06	9.29e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—EGF—breast cancer	3.35e-06	9.28e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP19A1—breast cancer	3.3e-06	9.16e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—STK11—breast cancer	3.3e-06	9.16e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—DPYD—breast cancer	3.26e-06	9.04e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MED12—breast cancer	3.26e-06	9.04e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—COMT—breast cancer	3.26e-06	9.03e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—MAPK3—breast cancer	3.24e-06	8.99e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTP1—breast cancer	3.24e-06	8.99e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALDOA—breast cancer	3.21e-06	8.9e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HMOX1—breast cancer	3.2e-06	8.87e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ITPR1—breast cancer	3.19e-06	8.85e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—BRAF—breast cancer	3.18e-06	8.83e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NCOA3—breast cancer	3.12e-06	8.64e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IGF1—breast cancer	3.1e-06	8.6e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AKT2—breast cancer	3.1e-06	8.59e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC2A2—breast cancer	3.09e-06	8.58e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—EGFR—breast cancer	3.09e-06	8.55e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—COMT—breast cancer	3.07e-06	8.51e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTP1—breast cancer	3.06e-06	8.47e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CPT1A—breast cancer	3.03e-06	8.4e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCG2—breast cancer	3.03e-06	8.4e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MTR—breast cancer	3.03e-06	8.4e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—TYMS—breast cancer	3.01e-06	8.36e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HMOX1—breast cancer	3.01e-06	8.36e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ITPR1—breast cancer	3.01e-06	8.34e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PLA2G4A—breast cancer	2.98e-06	8.26e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTM1—breast cancer	2.98e-06	8.26e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NCOR1—breast cancer	2.98e-06	8.26e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PIK3CD—breast cancer	2.98e-06	8.25e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HPGDS—breast cancer	2.97e-06	8.24e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HBA1—breast cancer	2.95e-06	8.19e-05	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PIK3CA—breast cancer	2.95e-06	8.18e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SERPINE1—breast cancer	2.94e-06	8.16e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—KRAS—breast cancer	2.91e-06	8.08e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ABCB1—breast cancer	2.89e-06	8.02e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTT1—breast cancer	2.88e-06	7.99e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ACHE—breast cancer	2.88e-06	7.99e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GPX1—breast cancer	2.85e-06	7.91e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—TYMS—breast cancer	2.84e-06	7.88e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP1A1—breast cancer	2.82e-06	7.83e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NOS3—breast cancer	2.81e-06	7.79e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NCOR1—breast cancer	2.81e-06	7.79e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.81e-06	7.79e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTM1—breast cancer	2.81e-06	7.79e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ERCC2—breast cancer	2.8e-06	7.77e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP17A1—breast cancer	2.73e-06	7.56e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ENO1—breast cancer	2.7e-06	7.49e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PTGS1—breast cancer	2.7e-06	7.49e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GPX1—breast cancer	2.69e-06	7.46e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PIK3CA—breast cancer	2.68e-06	7.42e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MDM2—breast cancer	2.67e-06	7.39e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP1A1—breast cancer	2.66e-06	7.38e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—RAF1—breast cancer	2.66e-06	7.37e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP2D6—breast cancer	2.65e-06	7.34e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—RELA—breast cancer	2.65e-06	7.34e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ERCC2—breast cancer	2.64e-06	7.32e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—MTHFR—breast cancer	2.63e-06	7.3e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ERBB2—breast cancer	2.63e-06	7.29e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NCOA2—breast cancer	2.6e-06	7.21e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MTOR—breast cancer	2.6e-06	7.19e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PIK3CB—breast cancer	2.6e-06	7.19e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—FASN—breast cancer	2.52e-06	6.99e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—BCHE—breast cancer	2.51e-06	6.96e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CXCL8—breast cancer	2.49e-06	6.91e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MTHFR—breast cancer	2.48e-06	6.88e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC5A5—breast cancer	2.48e-06	6.88e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HRAS—breast cancer	2.48e-06	6.87e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CDKN1B—breast cancer	2.44e-06	6.75e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CAV1—breast cancer	2.43e-06	6.73e-05	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—AKT1—breast cancer	2.41e-06	6.68e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC2A1—breast cancer	2.4e-06	6.64e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NQO1—breast cancer	2.4e-06	6.64e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CASP3—breast cancer	2.39e-06	6.62e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IL2—breast cancer	2.38e-06	6.61e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—IL6—breast cancer	2.37e-06	6.57e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCND1—breast cancer	2.32e-06	6.44e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—JUN—breast cancer	2.32e-06	6.43e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CTNNB1—breast cancer	2.3e-06	6.38e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP1B1—breast cancer	2.3e-06	6.37e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CAV1—breast cancer	2.29e-06	6.35e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MMP9—breast cancer	2.26e-06	6.25e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.25e-06	6.24e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CDKN1A—breast cancer	2.25e-06	6.23e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PTEN—breast cancer	2.24e-06	6.22e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3CG—breast cancer	2.21e-06	6.13e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MAPK8—breast cancer	2.19e-06	6.08e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NCOA1—breast cancer	2.19e-06	6.07e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—AKT1—breast cancer	2.19e-06	6.07e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—STK11—breast cancer	2.16e-06	5.99e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP19A1—breast cancer	2.16e-06	5.99e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3CG—breast cancer	2.09e-06	5.78e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SRC—breast cancer	2.08e-06	5.77e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—VEGFA—breast cancer	2.03e-06	5.62e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—COMT—breast cancer	2.01e-06	5.57e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—STAT3—breast cancer	2.01e-06	5.56e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTP1—breast cancer	2e-06	5.54e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HMOX1—breast cancer	1.97e-06	5.46e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ITPR1—breast cancer	1.97e-06	5.45e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3CD—breast cancer	1.95e-06	5.39e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALB—breast cancer	1.92e-06	5.32e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MAPK3—breast cancer	1.92e-06	5.31e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCB1—breast cancer	1.89e-06	5.24e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MYC—breast cancer	1.86e-06	5.17e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TGFB1—breast cancer	1.86e-06	5.15e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—TYMS—breast cancer	1.86e-06	5.15e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NOS3—breast cancer	1.84e-06	5.09e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NCOR1—breast cancer	1.84e-06	5.09e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.84e-06	5.09e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTM1—breast cancer	1.84e-06	5.09e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3CD—breast cancer	1.83e-06	5.08e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—EGFR—breast cancer	1.82e-06	5.05e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALB—breast cancer	1.81e-06	5.02e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GPX1—breast cancer	1.76e-06	4.87e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP1A1—breast cancer	1.74e-06	4.83e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NOS3—breast cancer	1.73e-06	4.8e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ERCC2—breast cancer	1.73e-06	4.79e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—KRAS—breast cancer	1.72e-06	4.77e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3CB—breast cancer	1.7e-06	4.7e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PTGS2—breast cancer	1.68e-06	4.66e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MTHFR—breast cancer	1.62e-06	4.5e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3CB—breast cancer	1.6e-06	4.43e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PTGS2—breast cancer	1.58e-06	4.39e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PIK3CA—breast cancer	1.58e-06	4.39e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TP53—breast cancer	1.53e-06	4.24e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CAV1—breast cancer	1.5e-06	4.15e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PTEN—breast cancer	1.47e-06	4.06e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HRAS—breast cancer	1.46e-06	4.06e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IL6—breast cancer	1.4e-06	3.88e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PTEN—breast cancer	1.38e-06	3.83e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3CG—breast cancer	1.36e-06	3.78e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AKT1—breast cancer	1.29e-06	3.58e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3CD—breast cancer	1.2e-06	3.32e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALB—breast cancer	1.18e-06	3.28e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NOS3—breast cancer	1.13e-06	3.14e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3CB—breast cancer	1.04e-06	2.9e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PTGS2—breast cancer	1.04e-06	2.87e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3CA—breast cancer	1.03e-06	2.87e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3CA—breast cancer	9.74e-07	2.7e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PTEN—breast cancer	9.03e-07	2.5e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—AKT1—breast cancer	8.44e-07	2.34e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—AKT1—breast cancer	7.96e-07	2.21e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3CA—breast cancer	6.37e-07	1.77e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AKT1—breast cancer	5.2e-07	1.44e-05	CbGpPWpGaD
